Andrew Limbek Net Worth

Mr. Andrew Limbek biography

Andrew Limbek is the VP of Fin. & Controller at Psychemedics.

How old is Mr Limbek?

Mr Limbek is 35, he's been the VP of Fin. & Controller of Psychemedics since . There are 10 older and no younger executives at Psychemedics. The oldest executive at Psychemedics Corp. is Harry Connick, 94, who is the Independent Director.

What's Mr Limbek's mailing address?

Andrew's mailing address filed with the SEC is C/O PSYCHEMEDICS CORPORATION, 289 GREAT ROAD, SUITE 200, ACTON, MA, 01720.

Insiders trading at Psychemedics

Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen a Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.

What does Psychemedics do?

psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics'​ clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.

Psychemedics executives and stock owners

Psychemedics executives and other stock owners filed with the SEC include:

• Raymond Kubacki,
  Chairman of the Board, President, Chief Executive Officer
• Raymond C. Kubacki,
  Chairman, CEO & Pres
• Charles Doucot,
  Executive Vice President
• Michael Schaffer,
  Vice President - Laboratory Operations
• Charles M. Doucot IV,
  Exec. VP
• Dr. Michael I. Schaffer Ph.D.,
  VP of Laboratory Operations
• A. Clinton Allen,
  Independent Director
• Fred Weinert,
  Independent Director
• Walter Tomenson,
  Independent Director
• Harry Connick,
  Independent Director
• Patrick J. Kinney Jr.,
  Sec.
• Sarah Ashby,
  VP & Gen. Counsel
• Andrew Limbek,
  VP of Fin. & Controller
• Annette Baumgartner,
  Founder
• Dr. Werner A. Baumgartner Ph.D.,
  Founder
• Peter Kamin,
  Director
• Neil Lerner,
  VP - Finance
• James V. Dyke,
  Vice President - Sales
• Michael Weisenhoff,
  
• Raymond J Ruddy,
  Vice President/Controller
• Jonathan D Compton,
  Vice President - Marketing
• William R Thistle,
  Sr. VP and Gen. Counsel
• Peter C Monson,
  VP, Treas., CFO & Asst. Sec.
• Jennifer Chmieleski,
  Vice President, Controller
• Richard T Christoph,
  10% owner
• William Dausey,
  Vice President of Sales
• Robyn C Davis,
  Director
• Andrew Reynolds,
  Director
• Shannon Shoemaker,
  Chief Revenue Officer
• Darius G Nevin,
  Director
• Brian Hullinger,
  President & CEO
• Daniella Mehalik,
  Vice President - Finance